At this time, New York Oncology Hematology does not have access to acquire and administer the new COVID prophylaxis shot Evusheld for immunocompromised patients. We await further guidance from NYS and will keep our patients updated.

About Us

NYOH participates in The Albany Business Review panel of experts: Impact of Consolidation on Health

6/13/2019

Ms. Sabrina Mosseau, Executive Director of New York Oncology Hematology was among three experts interviewed by The Albany Business Review to discuss how consolidation of health care impacts patients, health care providers and their budgets.

Read the article here